SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-035601
Filing Date
2020-11-06
Accepted
2020-11-06 16:31:22
Documents
4
Period of Report
2020-11-23
Effectiveness Date
2020-11-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea129467-def14a_soligenixinc.htm DEF 14A 113090
2 GRAPHIC image_001.jpg GRAPHIC 2131
3 GRAPHIC proxy_01.jpg GRAPHIC 235879
4 GRAPHIC proxy_02.jpg GRAPHIC 218981
  Complete submission text file 0001213900-20-035601.txt   676803
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 201294882
SIC: 2834 Pharmaceutical Preparations